Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tenon Medical, Inc. - Common Stock (NQ: TNON )

0.9857 -0.0543 (-5.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tenon Medical, Inc. - Common Stock

< Previous 1 2 Next >
Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
Via ACCESS Newswire
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
Via ACCESS Newswire
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
Via ACCESS Newswire
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
Via ACCESSWIRE
Tenon Medical(R) Announces Issuance of Three U.S. Patents
Via ACCESSWIRE
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
Via ACCESSWIRE
Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System
Via ACCESSWIRE
Tenon Medical Announces 1:8 Reverse Split
Via ACCESSWIRE
“The Future is Bright: Peraso Inc. (NASDAQ: PRSO) Expands Technology for Tactical Applications in High-Demand Industries – More Stocks Inside…”
Via AB Newswire
Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company’s New Catamaran(R) SE SI Joint Fusion System
Via ACCESSWIRE
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
Via ACCESSWIRE
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
Via ACCESSWIRE
Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
Tenon Medical Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
Via ACCESSWIRE
Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint
Via ACCESSWIRE
Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
Via ACCESSWIRE
Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results
Via ACCESSWIRE
Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant
Via ACCESSWIRE
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
Via ACCESSWIRE
Tenon Medical, Inc. Announces Second Adjournment of Special Meeting of Stockholders
Via ACCESSWIRE
Tenon Medical, Inc. Announces Adjournment of Special Meeting of Stockholders
Via ACCESSWIRE
Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results
Via ACCESSWIRE
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
Via ACCESSWIRE
Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Via ACCESSWIRE
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
Via ACCESSWIRE
Tenon Medical Announces Participation in Two Key Immersive Webinar Physician Training Programs Featuring the Company’s Catamaran(R) SI Joint Fusion System
Via ACCESSWIRE
Tenon Medical Announces Closing of $1.25 Million Secured Note Financing
Via ACCESSWIRE
Tenon Medical Reports Third Quarter 2023 Financial Results
Via ACCESSWIRE
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.